Prostate cancer
Not recruitingStudy on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
- Disease:Prostate cancer
- Substances:GozetotidePiflufolastat (18F)+1
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gozetotide
- Sponsor:Canisius Wilhelmina Ziekenhuis

